News|Videos|July 14, 2025
Your Opinion About Long-Acting PrEP: Fortune Effiong, Nigeria | IAS 2025
Author(s)Peter Wehrwein, Managing Editor
Advertisement
We asked people attending the International AIDS Society meeting in Kigali, Rwanda, their opinion about long-acting injectable HIV preexposure prophylaxis and what it could mean for HIV prevention. Fortune Effiong, a researcher at the University of Calabar Teaching Hospital in Nigeria, shared his views about the potential of self-injectable versions of PrEP.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
A conversation with Dolores Malaspina, M.D., about the generational impact of Holocaust trauma on schizophrenia risk
3
Intervention boosts connected insulin pen adoption among minorities with Type 1 diabetes
4
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
5






















